May 8, 2008

InNexus Biotechnology Hosts Inaugural Event of U.S. Department of Commerce -- To Highlight Foreign Direct Investment in USA with Invest in America Program --

BRITISH COLUMBIA, Canada- 8 May 2008 -InNexus Biotechnology Inc. (OTCBB: IXSBF)(TSX VENTURE: IXS), (http://www.ixsbio.com), a drug development company commercializing the next generation of monoclonal antibodies, yesterday hosted the U.S. Department of Commerce Invest in America event sponsored by the Greater Phoenix Economic Council at InNexus’ facilities located on the Campus of Mayo Clinic in Scottsdale, Arizona. The event highlighted the importance of Foreign Direct Investment (FDI) for jobs and economic growth through a series of site visits to foreign investor-owned facilities in States across the USA. Speakers at the event included Barry Broome, president of the Greater Phoenix Economic Council (GPEC), Holly Vineyard, deputy assistant secretary in the U.S. Department of Commerce, Aaron Brickman, director of Invest in America, and Jeff Morhet, President and CEO of InNexus Biotechnology Inc.

Jeff Morhet, President and CEO of
InNexus Biotechnology Inc. speaking to
members and guests of the GPEC

Glenn Williamson, Member of the Board of Directors for
InNexus Biotechnology Inc. meeting with
members and guests of GPEC